4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-23-016459
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 172,432 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | 2023-03-02 | Grant or award · Employee Stock Option (Right to Buy) | +110,032 | 110,032 | D | ||
| TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | 2023-03-02 | Grant or award · Restricted Stock Units | +62,400 | 62,400 | D | ||
Loading xslF345X03/doc4.xml…